Jeffrey L Wade - Net Worth and Insider Trading
Jeffrey L Wade Net Worth
The estimated net worth of Jeffrey L Wade is at least $306,636 dollars as of 2024-11-05. Jeffrey L Wade is the President and CFO of Lexicon Pharmaceuticals Inc and owns about 264,341 shares of Lexicon Pharmaceuticals Inc (LXRX) stock worth over $306,636. Details can be seen in Jeffrey L Wade's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey L Wade has not made any transactions after 2023-09-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey L Wade
Jeffrey L Wade Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey L Wade owns 1 companies in total, including Lexicon Pharmaceuticals Inc (LXRX) .
Click here to see the complete history of Jeffrey L Wade’s form 4 insider trades.
Insider Ownership Summary of Jeffrey L Wade
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2023-09-14 | EVP & Gen. Counsel |
Jeffrey L Wade Latest Holdings Summary
Jeffrey L Wade currently owns a total of 1 stock. Jeffrey L Wade owns 264,341 shares of Lexicon Pharmaceuticals Inc (LXRX) as of September 14, 2023, with a value of $306,636.
Latest Holdings of Jeffrey L Wade
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2023-09-14 | 264,341 | 1.16 | 306,636 |
Holding Weightings of Jeffrey L Wade
Jeffrey L Wade Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey L Wade has made a total of 2 transactions in Lexicon Pharmaceuticals Inc (LXRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Lexicon Pharmaceuticals Inc is the acquisition of 10,000 shares on September 14, 2023, which cost Jeffrey L Wade around $13,800.
Insider Trading History of Jeffrey L Wade
- 1
Jeffrey L Wade Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey L Wade's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey L Wade is -22.71%. GuruFocus also compares Jeffrey L Wade's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey L Wade within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey L Wade's insider trading performs compared to the benchmark.
Performance of Jeffrey L Wade
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.97 | | | | | |
| Relative Return to S&P 500(%) | -5.71 | | | | | |
Jeffrey L Wade Ownership Network
Ownership Network List of Jeffrey L Wade
Ownership Network Relation of Jeffrey L Wade
Jeffrey L Wade Owned Company Details
What does Lexicon Pharmaceuticals Inc do?
Who are the key executives at Lexicon Pharmaceuticals Inc?
Jeffrey L Wade is the EVP & Gen. Counsel of Lexicon Pharmaceuticals Inc. Other key executives at Lexicon Pharmaceuticals Inc include director & President and CEO Lonnel Coats , director & 10 percent owner Raymond Debbane , and SVP & Chief Commercial Officer Thomas Garner .
Lexicon Pharmaceuticals Inc (LXRX) Insider Trades Summary
Over the past 18 months, Jeffrey L Wade made 2 insider transaction in Lexicon Pharmaceuticals Inc (LXRX) with a net purchase of 22,000. Other recent insider transactions involving Lexicon Pharmaceuticals Inc (LXRX) include a net purchase of 170,000 shares made by Lonnel Coats , a net purchase of 16,000 shares made by Wendy Mcdermott , and a net purchase of 27,775,050 shares made by Artal International S.c.a. .
In summary, during the past 3 months, insiders sold 0 shares of Lexicon Pharmaceuticals Inc (LXRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexicon Pharmaceuticals Inc (LXRX) were sold and 29,183,050 shares were bought by its insiders, resulting in a net purchase of 29,183,050 shares.
Lexicon Pharmaceuticals Inc (LXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lexicon Pharmaceuticals Inc Insider Transactions
Jeffrey L Wade Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey L Wade. You might contact Jeffrey L Wade via mailing address: 8800 Technology Forest Place, The Woodlands Tx 77381.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
